Bio-Rad Laboratories Inc (BIO)
350.23
-12.97
(-3.57%)
USD |
NYSE |
Nov 14, 16:00
350.40
+0.17
(+0.05%)
Pre-Market: 08:02
Bio-Rad Laboratories Cash and Short Term Investments (Quarterly): 1.622B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.622B |
| June 30, 2024 | 1.616B |
| March 31, 2024 | 1.646B |
| December 31, 2023 | 1.607B |
| September 30, 2023 | 1.759B |
| June 30, 2023 | 1.723B |
| March 31, 2023 | 1.851B |
| December 31, 2022 | 1.791B |
| September 30, 2022 | 1.850B |
| June 30, 2022 | 1.968B |
| March 31, 2022 | 2.073B |
| December 31, 2021 | 869.92M |
| September 30, 2021 | 1.337B |
| June 30, 2021 | 1.161B |
| March 31, 2021 | 1.020B |
| December 31, 2020 | 991.12M |
| September 30, 2020 | 1.154B |
| June 30, 2020 | 1.032B |
| March 31, 2020 | 1.037B |
| December 31, 2019 | 1.115B |
| September 30, 2019 | 979.25M |
| June 30, 2019 | 981.86M |
| March 31, 2019 | 858.99M |
| December 31, 2018 | 844.80M |
| September 30, 2018 | 860.57M |
| Date | Value |
|---|---|
| June 30, 2018 | 818.25M |
| March 31, 2018 | 762.93M |
| December 31, 2017 | 754.98M |
| September 30, 2017 | 716.46M |
| June 30, 2017 | 712.85M |
| March 31, 2017 | 674.08M |
| December 31, 2016 | 839.44M |
| September 30, 2016 | 806.12M |
| June 30, 2016 | 791.60M |
| March 31, 2016 | 748.66M |
| December 31, 2015 | 786.27M |
| September 30, 2015 | 786.08M |
| June 30, 2015 | 727.65M |
| March 31, 2015 | 710.69M |
| December 31, 2014 | 697.64M |
| September 30, 2014 | 702.58M |
| June 30, 2014 | 647.58M |
| March 31, 2014 | 641.33M |
| December 31, 2013 | 608.92M |
| September 30, 2013 | 561.82M |
| June 30, 2013 | 834.43M |
| March 31, 2013 | 836.83M |
| December 31, 2012 | 921.07M |
| September 30, 2012 | 853.62M |
| June 30, 2012 | 835.26M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
869.92M
Minimum
Dec 2021
2.073B
Maximum
Mar 2022
1.461B
Average
1.612B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Agilent Technologies Inc | 1.779B |
| Bruker Corp | 148.10M |
| Azenta Inc | 595.84M |
| Harvard Bioscience Inc | 4.569M |
| Bionano Genomics Inc | 18.94M |